Biocon gets 6 observations from USFDA after inspection of its Bengaluru plant

Biocon is confident of addressing these expeditiously and remains committed to global standards of quality and compliance, the statement added.

Source: The Economic Times Healthcare and Biotech News - March 5, 2019 Category: Pharmaceuticals Source Type: news